Nothing Special   »   [go: up one dir, main page]

FR2290891A1 - SUPPORT INTENDED TO SLOWLY RELEASE AN ACTIVE BODY, IN PARTICULAR A MEDICINAL PRODUCT, AND ITS MANUFACTURE - Google Patents

SUPPORT INTENDED TO SLOWLY RELEASE AN ACTIVE BODY, IN PARTICULAR A MEDICINAL PRODUCT, AND ITS MANUFACTURE

Info

Publication number
FR2290891A1
FR2290891A1 FR7534821A FR7534821A FR2290891A1 FR 2290891 A1 FR2290891 A1 FR 2290891A1 FR 7534821 A FR7534821 A FR 7534821A FR 7534821 A FR7534821 A FR 7534821A FR 2290891 A1 FR2290891 A1 FR 2290891A1
Authority
FR
France
Prior art keywords
manufacture
medicinal product
active body
slowly release
support intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7534821A
Other languages
French (fr)
Other versions
FR2290891B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FR2290891A1 publication Critical patent/FR2290891A1/en
Application granted granted Critical
Publication of FR2290891B1 publication Critical patent/FR2290891B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nanotechnology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7534821A 1974-11-14 1975-11-14 SUPPORT INTENDED TO SLOWLY RELEASE AN ACTIVE BODY, IN PARTICULAR A MEDICINAL PRODUCT, AND ITS MANUFACTURE Granted FR2290891A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US523720A US3926188A (en) 1974-11-14 1974-11-14 Laminated drug dispenser

Publications (2)

Publication Number Publication Date
FR2290891A1 true FR2290891A1 (en) 1976-06-11
FR2290891B1 FR2290891B1 (en) 1978-11-10

Family

ID=24086191

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7534821A Granted FR2290891A1 (en) 1974-11-14 1975-11-14 SUPPORT INTENDED TO SLOWLY RELEASE AN ACTIVE BODY, IN PARTICULAR A MEDICINAL PRODUCT, AND ITS MANUFACTURE

Country Status (10)

Country Link
US (1) US3926188A (en)
JP (1) JPS6059203B2 (en)
CA (1) CA1056685A (en)
CH (1) CH634226A5 (en)
DE (1) DE2549856C2 (en)
FR (1) FR2290891A1 (en)
GB (1) GB1477813A (en)
IT (1) IT1050619B (en)
MX (2) MX158868A (en)
SE (1) SE439432B (en)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182330A (en) * 1977-07-25 1980-01-08 Alza Corporation Means for administering amphipathic medicament
US4304232A (en) * 1979-03-14 1981-12-08 Alza Corporation Unit system having multiplicity of means for dispensing useful agent
AU539868B2 (en) * 1979-09-12 1984-10-18 Eli Lilly And Company Device for drug delivery to ruminants
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
JPS5770816A (en) * 1980-10-17 1982-05-01 Ono Pharmaceut Co Ltd Multilayered film preparation of prostagladin of prolonged action
DE3115763A1 (en) * 1981-04-18 1982-11-04 Edgar Dr.med. 6238 Hofheim Lenhard Medical depot probe for the local protracted release of active substance
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
JPS58134019A (en) * 1982-02-05 1983-08-10 Ono Pharmaceut Co Ltd Slow-releasing triple-layered film pharmaceutical containing prostaglandin and its preparation
US4571039A (en) * 1983-04-15 1986-02-18 Stanley Poler Eye-medicating contact-lens construction
US4639244A (en) * 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
US4564364A (en) * 1983-05-26 1986-01-14 Alza Corporation Active agent dispenser
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
US4863445A (en) * 1984-07-30 1989-09-05 Baxter Travenol Laboratories, Inc. Assembly for inhibiting microbial growth in collected fluid
US4693895A (en) * 1984-10-26 1987-09-15 Alza Corporation Colon delivery system
US4627851A (en) * 1984-10-26 1986-12-09 Alza Corporation Colonic-therapeutic delivery system
CH667001A5 (en) * 1985-09-03 1988-09-15 Hugo Degen UNDER MATTRESS.
US4880633A (en) * 1986-03-12 1989-11-14 Merck & Co., Inc. Transdermal drug delivery system
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4841968A (en) * 1986-09-26 1989-06-27 Southern Research Institute Antithrombotic/thrombolytic suture and methods of making and using the same
US4830860A (en) * 1986-10-30 1989-05-16 Pfizer Inc. Stressed polymeric device for controlled release of a substance to an ambient environment
JPS63143581A (en) * 1986-12-05 1988-06-15 Nissha Printing Co Ltd Hologram molded article
US4892778A (en) * 1987-05-27 1990-01-09 Alza Corporation Juxtaposed laminated arrangement
DE3879031T2 (en) * 1987-08-08 1993-06-24 Akzo Nv CONCEPTUAL IMPLANT.
DK530787D0 (en) * 1987-10-09 1987-10-09 Bukh Meditec DEVICE FOR INTRODUCTION IN A BODY
US5035886A (en) * 1987-10-19 1991-07-30 Ppg Industries, Inc. Active agent delivery device
US4959208A (en) * 1987-10-19 1990-09-25 Ppg Industries, Inc. Active agent delivery device
US5071645A (en) * 1987-10-19 1991-12-10 Ppg Industries, Inc. Process of producing an active agent delivery device
US4781924A (en) 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
GB8815968D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Veterinary devices
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
CA2088982A1 (en) * 1990-08-09 1992-02-10 Robert J. Leonard Multiple drug delivery system
JPH0444666U (en) * 1990-08-22 1992-04-15
JPH0444601U (en) * 1990-08-22 1992-04-15
US5538735A (en) * 1993-02-19 1996-07-23 Ahn; Sam S. Method of making a drug delivery system using hollow fibers
JP3720386B2 (en) * 1993-12-27 2005-11-24 住友製薬株式会社 Drug release controlled formulation
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
EP1284137B1 (en) * 2000-05-26 2010-12-01 TAKADA, Kanji Nonoral preparation having three-layer structure
US20020148138A1 (en) * 2001-04-06 2002-10-17 Egan Brian A. Smart tread boot covers
CA2450771C (en) 2001-06-12 2010-09-07 Johns Hopkins University School Of Medicine Reservoir device for intraocular drug delivery
US7306580B2 (en) * 2003-04-16 2007-12-11 Cook Incorporated Medical device with therapeutic agents
WO2005004837A1 (en) * 2003-07-10 2005-01-20 Galen (Chemicals) Limited Intravaginal drug delivery devices
CN1882338A (en) * 2003-09-18 2006-12-20 马库赛特公司 Transscleral delivery
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
DE102004050457A1 (en) * 2004-10-12 2006-04-13 Capsulution Nanoscience Ag Segmented device for the sustained release of molecules in the tangential direction through thin films and applications thereof
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
US20060258698A1 (en) 2005-02-09 2006-11-16 Sreenivasu Mudumba Liquid formulations for treatment of diseases or conditions
KR20140093764A (en) 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 Stable formulations, and methods of their preparation and use
CA2645488C (en) 2006-03-23 2014-09-02 Macusight, Inc. Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
SG2014007389A (en) 2009-01-29 2014-04-28 Forsight Vision4 Inc Posterior segment drug delivery
ES2921527T3 (en) 2009-06-03 2022-08-29 Forsight Vision5 Inc Anterior segment drug delivery
US20110066141A1 (en) * 2009-09-11 2011-03-17 Cook Incorporated Implantable medical device having an anti-gastric distress agent
US20110098797A1 (en) * 2009-10-23 2011-04-28 Cleek Robert L Drug eluting composite
US9320890B2 (en) * 2009-11-09 2016-04-26 W. L. Gore & Associates, Inc. Drug eluting composite
US9504771B2 (en) 2009-11-09 2016-11-29 W. L. Gore & Associates, Inc. Drug eluting composite
US10111830B2 (en) 2010-03-16 2018-10-30 Titan Pharmaceuticals, Inc. Heterogeneous implantable devices for drug delivery
WO2012019139A1 (en) 2010-08-05 2012-02-09 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
EP2600812B1 (en) 2010-08-05 2021-09-22 ForSight Vision4, Inc. Apparatus to treat an eye
DK2600930T3 (en) 2010-08-05 2021-03-01 Forsight Vision4 Inc Injection device for drug delivery
AU2011329656B2 (en) 2010-11-19 2017-01-05 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
WO2013003620A2 (en) 2011-06-28 2013-01-03 Forsight Vision4, Inc. Diagnostic methods and apparatus
EP2739252A4 (en) 2011-08-05 2015-08-12 Forsight Vision4 Inc Small molecule delivery with implantable therapeutic device
ES2912370T3 (en) 2011-09-14 2022-05-25 Forsight Vision5 Inc Eye Insertion Apparatus
EP2755600B1 (en) 2011-09-16 2021-03-17 ForSight Vision4, Inc. Fluid exchange apparatus
WO2013056213A1 (en) * 2011-10-14 2013-04-18 Purdue Research Foundation Ingestible multi-sheet unit having predetermined functions and combinations
HUE046128T2 (en) 2012-10-26 2020-02-28 Forsight Vision5 Inc Ophthalmic system for sustained release of drug to eye
US9968603B2 (en) 2013-03-14 2018-05-15 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
EP4302736A3 (en) 2013-03-28 2024-04-03 ForSight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
EP3177289A4 (en) 2014-08-08 2018-03-21 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
US10226419B2 (en) * 2014-09-08 2019-03-12 ProMed Pharma, LLC Methods for manufacturing implants
SG11201703726XA (en) 2014-11-10 2017-06-29 Forsight Vision4 Inc Expandable drug delivery devices and method of use
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
MX2018006234A (en) 2015-11-20 2018-08-14 Forsight Vision4 Inc Porous structures for extended release drug delivery devices.
JP7009384B2 (en) 2016-04-05 2022-01-25 フォーサイト・ビジョン フォー・インコーポレーテッド Implantable eye drug delivery device
CN111655206B (en) 2017-11-21 2022-10-14 弗赛特影像4股份有限公司 Fluid exchange device for expandable port delivery system and method of use
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3630200A (en) * 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3832252A (en) * 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
US3416530A (en) * 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
US3618604A (en) * 1969-06-09 1971-11-09 Alza Corp Ocular insert
US3625214A (en) * 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US3797485A (en) * 1971-03-26 1974-03-19 Alza Corp Novel drug delivery device for administering drug into blood circulation in blood vessel
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3630200A (en) * 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3832252A (en) * 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device

Also Published As

Publication number Publication date
DE2549856C2 (en) 1985-01-03
MX158868A (en) 1989-03-27
CH634226A5 (en) 1983-01-31
DE2549856A1 (en) 1976-05-20
JPS6059203B2 (en) 1985-12-24
JPS5170807A (en) 1976-06-18
SE7512744L (en) 1977-05-15
GB1477813A (en) 1977-06-29
IT1050619B (en) 1981-03-20
US3926188A (en) 1975-12-16
MX158867A (en) 1989-03-27
FR2290891B1 (en) 1978-11-10
CA1056685A (en) 1979-06-19
SE439432B (en) 1985-06-17

Similar Documents

Publication Publication Date Title
FR2290891A1 (en) SUPPORT INTENDED TO SLOWLY RELEASE AN ACTIVE BODY, IN PARTICULAR A MEDICINAL PRODUCT, AND ITS MANUFACTURE
SE413285B (en) PROVIDED TO MANUFACTURE A PHARMACEUTICAL CARRIER IN FILM FORM WITH INCORPORATED ACTIVE SUBSTANCE
AT347588B (en) MEDICINAL ACTIVE SUBSTANCE
NL7505574A (en) MEDICINAL CATAMENTAL TAMPON.
IT7849462A0 (en) CAPSULE BODY IN PARTICULAR FOR A CAPSULE FOR THE ADMINISTRATION OF MEDICINAL SUBSTANCES AS WELL AS THE PROCEDURE AND DEVICE FOR ITS PRODUCTION
NL930058I1 (en) Process for the preparation of a drug containing 15-deoxy-16-oxygenated prostanoic acid derivatives with anti-gastric juice secreting action and for a prostanoic acid derivative suitable for use in this process
ZA754305B (en) Medicament carriers in the form of foil having active substance incorporated therein
DK137785B (en) Dental and oral care product.
JPS5555113A (en) Oral administration medical tablet and its manufacture
AR206618A1 (en) ENZYMATICALLY DEGRADABLE BIODESGASTABLE AGENT USEFUL AS A VEHICLE TO SUPPLY A SLIGHTLY WATER-SOLUBLE DRUG
IL46499A0 (en) Analgesic formulations having enhanced therapeutic activity and comprising a naphthyl propionic acid derivative
DK137681B (en) INSECTICIDES AND ACARICIDES ACTIVE O-ETHYL-S-N-PROPYL -O-VINYL-THIONOTHIOLPHOSPHORIC ACID ESTERS
BE796196A (en) CATALYTICALLY ACTIVE BODY
NL166010C (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-ARTERIOSCLEROTIC EFFICIENCY, MEDICINAL PRODUCT AND METHOD FOR THE PREPARATION OF ANTI-ARTERIOSCLEROTICALLY ACTIVE ABETAMIDE DERIVATIVES
AR223990A1 (en) A PROCEDURE TO PRODUCE A NOVEL PHARMACEUTICAL COMPOSITION CONTAINING ARYLTRIFLUOROETHANOL, WITH ANALGESIC, ANTIPIRETIC AND / OR ANTI-INFLAMMATORY ACTIVITY
ZA75790B (en) New 2-amino-6-dialkylaminodihydropyridines their production and their medicinal use
FR2281766A1 (en) OESTRATETRAENES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
BE842348A (en) NEW STABLE PHARMACEUTICAL SOLUTIONS AND THEIR PREPARATION
JPS5377073A (en) Piperadine derivative compound and its production and medical drugs containing said compound
FR2335232A1 (en) PHARMACEUTICAL COMPOSITIONS WITH ANTI-CONVULSIVE PROPERTIES CONTAINING PHENYLSILANES
BE839309A (en) NEW ANTIBIOTIC, ITS PREPARATION AND THE MEDICINAL PRODUCT CONTAINING IT
FR2314719A1 (en) NEW DRUG, ESPECIALLY DIURETIC
DK137129C (en) INSECTICIDES AND ACARICIDES ACTIVE O-PHENYLTHIONOTHIOLPHOSPHORIC ACID RESIDENTS
BE843255A (en) NEW TERPENOAROMATIC AMIDINES FOR USE AS A MEDICINAL PRODUCT
DK133988C (en) INSECTICIDES AND ACARICIDES ACTIVE 0-ETHYL-0-N-PROPYL-0-VINYL-THIONOPHOSPHORIC ACID RESIDENTS

Legal Events

Date Code Title Description
ST Notification of lapse